Finevit D3 supports healthy bones, skin, and immune function. An easy-to-use, high-quality supplement.
Colecalciferolum
Finevit-D3 2000
Vitamin D3 (Cholecalciferol)
Orally dispersible tablets
Each orally dispersible tablet contains:
Vitamin D3 (Cholecalciferol) USP 2000 IU
(Corresponding vitamin supplement)
Vitamin supplement
Vitamin D3 orally dispersible tablets 2000 IU are indicated in adults, elderly, and adolescents for the prevention and treatment of Vitamin D deficiency.
In patients at risk of Vitamin D deficiency or insufficiency, they are used as an adjunct in osteoporosis treatment.
Pediatric Population:
Vitamin D3 orally dispersible tablets are not recommended for children under 12 years of age.
Treatment of Deficiency:
Adults: 50,000 IU/week for 6 weeks or 3,000–4,000 IU/day for 10–12 weeks.
Adolescents aged 12 years or older: 25,000 IU once every 2 weeks for 6 weeks (total dose 75,000 IU) or 2,000 IU/day for 6 weeks.
Maintenance Therapy After Deficiency Treatment:
Adults: 25,000 IU/month or 1,000 IU/day. In certain situations, dose increase up to 50,000 IU/month or 4,000 IU/day may be required if low doses are insufficient to maintain levels.
Adolescents aged 12 years or older: 1,000 IU/day.
After starting maintenance therapy, 25(OH)D levels should be checked approximately every 3–4 months to confirm target achievement.
Prevention of Deficiency:
Adults: 25,000 IU/month or 1,000 IU/day. In certain situations, dose increase up to 50,000 IU/month or 4,000 IU/day may be necessary if low doses do not maintain adequate levels.
Adolescents aged 12 years or older: 25,000 IU every 6 weeks.
Alongside Specific Osteoporosis Therapy:
Adults: 25,000 IU/month or 1,000 IU/day.
High-Risk Populations May Require Higher Doses:
Institutionalized or long-term hospitalized individuals
Dark-skinned individuals, especially at high latitudes
Limited sun exposure, body covered with clothing, or use of sunscreen
Obese individuals
Patients concurrently taking certain medications (e.g., anticonvulsants, glucocorticoids)
Conditions causing malabsorption, including inflammatory bowel and abdominal diseases
Patients with osteoporosis
Individuals recently treated for Vitamin D deficiency requiring maintenance therapy
Orally. Place on the tongue, allow to dissolve, and then swallow. Tablets can be taken with food.
Hypersensitivity to active substance(s) or excipients
Vitamin D hypervitaminosis
Nephrolithiasis
Nephrocalcinosis
